Understanding immune cell responses in various conditions
Official title: Core D: Data and Informatics Service Core
Funded at University of Alabama at Birmingham · NIH-11075858 · Data updated 2026-11-12
This study looks at how certain immune cells in your body react to different situations like infections and inflammation, using advanced technology to better understand how your immune system works, which could help improve treatments for various health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | April 16, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $434,363 |
| NIH project number | 5U19AI181105-02 |
| Project ID | NIH-11075858 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals with conditions affecting their immune response, such as autoimmune diseases or those undergoing organ transplantation.
✕Less likely to help
Patients with stable immune conditions or those not experiencing immune-related issues may not benefit from this research.
What this research studies
This research investigates how B and T cells respond to different challenges such as tissue residency, viral infections, and immune reactions. It utilizes advanced data management and bioinformatics to analyze complex biological data, integrating clinical information to enhance understanding of immune responses. Patients' immune profiles will be studied through high-throughput sequencing and other data-rich approaches, aiming to improve the understanding of immune system behavior in various contexts.
Why it matters
Potential benefit: If successful, this research could lead to better strategies for managing immune-related conditions and improving patient outcomes.
How similar studies have gone: Previous research has shown promise in using data-driven approaches to understand immune responses, indicating potential for success in this area.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Rosenberg, Alexander — University of Alabama at Birmingham
- Study coordinator: Rosenberg, Alexander
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Exploring how Down syndrome affects optic nerve health in kids
A study using a mouse model to understand why optic nerve problems are common in children with Down syndrome and how to prevent them.
-
Global bromocriptine trial for postpartum cardiomyopathy
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with peripartum cardiomyopathy.
-
Global Bromocriptine Add-on for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding the dopamine agonist bromocriptine to standard heart failure care helps postpartum women with a specific heart condition.
-
Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.
-
Bromocriptine as add-on therapy for postpartum cardiomyopathy across multiple sites
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with postpartum cardiomyopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.